|
Uteruskrebs Zervixkrebs 60 Arzneien anan. aln-g. alumn. anan. arg-mur. arg-n. arn. ars-i. aur. aur-m. aur-m-n. bomh. bufo. cadm-s. calth. carb-ac. carb-an. carc. con. cub. cund. cur. dios. fl-ac. form-ac. graph. hir. hist. hydr. hydrc. iod. kali-ar. kali-i. kreos.*** lach. lil-t. lyc. med. merc. merc-c. murx. nat-f. nat-m. nat-sil. nit-ac. phos. phyt. puls. rad-br. sec. sep. sul-ac. tamox. tarent. thlas. thuj. thymol. ust. vesp. x-ray. keine Fälle=ein- >1-2 Fälle=zwei- >2 Fälle=Drei- >5 Fälle=Vier- >10 Fälle=FÜNF-wertig ()=BegleitTherapie *=palliativ **=TeilWirkung ***=1-Jahr ****5-Jahre-Nachbeobachtung Complete-Nachträge wichtig, bzw. verlässlich |
| ^ | anan | Allen, CR |
| ^ | aln-g | lby5 |
| ^ | alumn | lby5 |
| ^ | anan | lby5 |
| ^ | arg-mur | gm |
| ^ | arg-n | sgx, sne2:H.Farrington |
| ^ | arn | banj |
| ^ | ars-i | sne |
| ^ | aur | Johnstone, HP1885 |
| ^ | aur-m | Ismail, CR |
| ^ | aur-m-n | rmk1 |
| ^ | bomh | gm1 |
| ^ | bufo | lby5 |
| ^ | cadm-s | Choudhary, CR |
| ^ | calth | cpb |
| ^ | carb-ac | lby5 |
| ^ | carb-an | bro1, banj |
| ^ | carc | rmk1 |
| ^ | con | k, banj, sne |
| ^ | cub | lby5 |
| ^ | cund | sne |
| ^ | cur | lby5 |
| ^ | dios | Choudhary, CR |
| ^ | fl-ac | lby5 |
| ^ | form-ac | Muttathukunnel, CR |
| ^ | graph | k |
| ^ | hir | jl |
| ^ | hist | jl |
| ^ | hydr | sgx, sne |
| ^ | hydrc | lby5 |
| ^ | iod | bro1, sne |
| ^ | kali-ar | lby5 |
| ^ | kali-i | T.F.Allen |
| ^ | kreos | carl*** bro1, ftb in cpb1 |
| ^ | lach | rmk1 |
| ^ | lil-t | rmk1 |
| ^ | lyc | lby5 |
| ^ | med | lby5 |
| ^ | merc | lby5 |
| ^ | merc-c | lby5 |
| ^ | murx | lby5 |
| ^ | nat-f | sne |
| ^ | nat-m | sne |
| ^ | nat-sil | k |
| ^ | nit-ac | sgx |
| ^ | phos | rmk1 |
| ^ | phyt | lby5 |
| ^ | puls | rmk1 |
| ^ | rad-br | lby5 |
| ^ | sec | lby5 |
| ^ | sep | rmk1 |
| ^ | sul-ac | lby5 |
| ^ | tamox | =Toxikologie, lby6 |
| ^ | tarent | ptk1 |
| ^ | thlas | Clarke, CR |
| ^ | thuj | br |
| ^ | thymol | sp |
| ^ | ust | lby5 |
| ^ | vesp | lby5 |
| ^ | x-ray | lby5 |